LENZ Therapeutics Inc (LENZ) — Financial Flexibility Index
LENZ Therapeutics Inc (LENZ) has a Financial Flexibility Index of -1.53x as of December 2025. Free cash flow of $-32.99 Million (operating CF $-33.02 Million minus capex $38.00K) represents -2% of total liabilities ($21.54 Million). Check LENZ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LENZ Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for LENZ Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see LENZ Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for LENZ Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for LENZ Therapeutics Inc. Explore cash flow to debt ratio of LENZ Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.17x | $-68.34 Million | $-69.17 Million | $21.54 Million | ▲ +39.6% |
| 2024 | -5.25x | $-58.92 Million | $-59.39 Million | $11.22 Million | ▼ -1319.2% |
| 2023 | -0.37x | $-60.35 Million | $-60.38 Million | $163.09 Million | ▲ +67.7% |
| 2022 | -1.14x | $-81.39 Million | $-87.98 Million | $71.12 Million | ▲ +20.9% |
| 2021 | -1.45x | $-47.11 Million | $-52.85 Million | $32.55 Million | ▼ -552.8% |
| 2020 | -0.22x | $-7.18 Million | $-8.72 Million | $32.36 Million | ▼ -2495.4% |
| 2019 | -0.01x | $-19.00K | $-19.00K | $2.22 Million | — |